MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fpsyt.2023.1163989

Медицинская библиотека · Frontiers in psychiatry · 2023

Prevalence and incidence of neuropsychiatric disorders in post hospitalized COVID-19 patients in South America: a systematic review and meta-analysis.

Perea-Flórez Francisco, Javier-Murillo Nair, Lapeyre-Rivera André, Gamonal Bryan, Cabanillas-Lazo Miguel, Velásquez-Rimachi Victor, Alva-Diaz Carlos

Систематический обзорСтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

There are multiple reports of neuropsychiatric disorders (NDs) such as stress, depression, post-traumatic stress disorder (PTSD), or anxiety, in patients who have survived the acute phase of COVID-19, being even more frequent in people who were hospitalized with moderate or severe disease. South America (SA) was one of the most affected continents during this time due to its health, social, political and economic context. We aimed to determine the prevalence and incidence of NDs in patients following hospitalization for COVID-19 in SA.

MATERIALS AND

METHODS

We searched in PubMed, Embase, Scopus, Web of Science, LILACS, SciELO, and Google Scholar databases up to October 2022. We performed proportion meta-analysis with a random-effect model and Freeman-Tukey Double Arcsine transformation using the STATA 16.1 program. Finally, we evaluated heterogeneity by subgroup analysis and certainty of evidence with the GRADE approach.

RESULTS

We included eight studies from four countries. We only pooled six studies with prevalence measures. The estimated prevalence of all NDs was 31.48% (two-studies, 95%CI: 25.82-37.43). Depression, anxiety, insomnia, PTSD, and memory alterations had a pooled prevalence of 16.23% (three-studies, 95%CI: 7.18-27.93, I2: 94.22), 18.72% (three-studies, 95%CI: 11.65-26.97, I2: 87.56), 43.07% (three-studies, 95%CI: 32.77-53.37, I2: 92.61), 31.78% (three-studies, 95%CI: 14.33-52.40, I2: 97.96), and 38.24% (two-studies, 95%CI: 35.5-40.97), respectively. The evidence included was deemed as moderate to high certainty.

CONCLUSION

We suggest that NDs should be prioritized in research and care in South America with public policies that can support their identification and prompt management to improve the quality of life of patients. More studies are needed to adequately study the prevalence of NDs in South America, their associated factors, and evaluate the causes of heterogeneity.

SYSTEMATIC REVIEW REGISTRATION: https://doi.org/10.6084/m9.figshare.21901041.v1.

Для цитирования: Perea-Flórez Francisco, Javier-Murillo Nair, Lapeyre-Rivera André, Gamonal Bryan, Cabanillas-Lazo Miguel, Velásquez-Rimachi Victor, Alva-Diaz Carlos. Prevalence and incidence of neuropsychiatric disorders in post hospitalized COVID-19 patients in South America: a systematic review and meta-analysis.. Frontiers in psychiatry. 2023. DOI: 10.3389/fpsyt.2023.1163989.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.